CMO, from local requirements to an FDA agreement

被引:0
|
作者
Cauvet, J [1 ]
机构
[1] LCO Sante, F-95520 Osny, France
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Reaching an FDA agreement requires human and financial resources. These resources have to be set up at the right place and at the right moment, in particular within a subcontracting organisation where there obviously is a limit. The full involvement of the top management is critical. A lot of money will be spent without any short term results. In parallel, a new organisation has to be set up to implement FDA requirements.
引用
收藏
页码:34 / 35
页数:2
相关论文
共 50 条
  • [21] From requirements agreement to changes integration: keys for not failing in construction projects
    Cerezo-Narvaez, Alberto
    Otero-Mateo, Manuel
    Pastor-Fernandez, Andres
    DYNA, 2017, 92 (03): : 254 - 254
  • [22] Lake management requirements from a local perspective
    James, MR
    Vant, W
    Severne, C
    FRESHWATER MANAGEMENT: GLOBAL VERSUS LOCAL PERSPECTIVES, 2003, : 191 - 216
  • [23] Agreement for local hospitals
    不详
    RADIOLOGE, 2008, 48 (05): : 524 - 524
  • [24] Requirements for service level agreement management
    Marilly, E
    Martinot, O
    Betgé-Brezetz, S
    Delègue, G
    2002 IEEE WORKSHOP ON IP OPERATIONS AND MANAGEMENT, 2002, : 57 - 62
  • [25] EC–FDA mutual recognition agreement proves difficult
    John Hodgson
    Nature Biotechnology, 1997, 15 : 119 - 120
  • [26] NEW ZEALAND SIGNS FOOD SAFETY AGREEMENT WITH FDA
    不详
    FOOD AUSTRALIA, 2013, 65 (01): : 8 - 8
  • [27] FDA releases proposed terms of PDUFA VII agreement
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (10) : 728 - 728
  • [28] FDA releases proposed terms of PDUFA VII agreement
    Asher Mullard
    Nature Reviews Drug Discovery, 2021, 20 : 728 - 728
  • [29] Regulation: FDA revises postmarketing reporting requirements
    Rios, Maribel
    Pharmaceutical Technology, 2007, 31 (11)
  • [30] What are the most important legal issues a company must address before signing an agreement with a CMO?
    DeAngelis
    Haywood
    Rogus
    Westerberg
    Wilson
    Wirth
    Zucconi
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (14): : A14 - A15